サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：耳管デバイスの世界市場-2023年～2030年
市場調査レポート
商品コード
1373398

耳管デバイスの世界市場-2023年～2030年

Global Ear Tube Devices Market - 2023-2030

出版日
ページ情報
英文 190 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
耳管デバイスの世界市場-2023年～2030年
出版日: 2023年10月18日
発行: DataM Intelligence
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

鼓膜切開チューブや通気チューブとしても知られる耳管留置器は、慢性中耳炎（中耳に液体がたまる）や再発性外耳炎などの治療に用いられる、小型で一般的に円筒形の留置器です。これらのチューブは、小手術によって鼓膜に挿入され、一時的な通路を形成して圧力を均一化し、中耳から液体を排出します。このチューブの主な目的は、症状を緩和し、聴力を改善し、感染症の再発を予防することです。

耳管は通常、生体適合性と耐久性を考慮して選択されたシリコン、プラスチック、金属などのさまざまな材料で構成されています。イヤーチューブは、耳の健康と全体的な生活の質を向上させることで、個人、特に子供のしつこい耳の問題の治療に重要な役割を果たしています。

市場力学：市場促進要因と市場抑制要因

革新的なイヤーチューブデザインは、耳感染症の治療効果を高めるために液体を注入した材料を使用しており、市場成長の原動力になると予想されます

2023年、ハーバード大学Wyss Institute for Biologically Inspired Engineering、ハーバード大学John A. Paulson School of Engineering and Applied Sciences、ボストンのMassachusetts Eye and Earの研究チームが共同で、「鼓膜切開チューブ」（TTs）と呼ばれる画期的な新しいタイプの耳管装置を開発しました。このチューブは、液体を注入する材料を使用し、独自の湾曲した内腔形状により、ドラッグデリバリーや体液の排出を促進し、細菌の付着を防止します。

耳管デバイス市場は、強化された機能性とヒト患者での臨床試験の可能性を有する革新的なiTTs「鼓膜切開チューブ」（TTs）のイントロダクションより成長が期待されます。これらのiTTsは、従来のTTsの限界に対処する上で大きな進歩をもたらし、特に小児の耳感染症の治療選択肢の改善を求めるヘルスケアプロバイダーや親にとって好ましい治療選択肢となっています。この技術は、脳用シャントや胆管用シャントなど、他の埋め込み型医療導管に対する設計アプローチに汎用性があるため、市場の範囲を拡大し、より広範な医療関係者や患者にアピールできる可能性があります。

したがって、この技術革新は、中耳の疾患を抱える患者により安全で、より効率的で、カスタマイズ可能なソリューションを提供することで、耳管デバイスの市場に革命をもたらす可能性を秘めています。これにより、ヘルスケア分野への需要と投資が促進されるであろう。

さらに、高齢者人口の増加、イヤーチューブの利点に関する認知度の向上、耳感染症の発生率の増加、低侵襲処置の需要の増加が、予測期間中に市場を牽引すると予想される要因です。

阻害要因：

患者や医療従事者の間では、耳管デバイスの利点に関する認識が不足しており、患者や医師によっては投薬や経過観察などの代替治療が好まれる場合があります。さらに、耳管挿入に伴う潜在的な合併症や副作用に対する懸念が、このような嗜好をさらに助長している可能性があります。このような要因から、イヤーチューブ市場は予測期間中に縮小すると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 液体注入材料を用いた革新的なイヤーチューブデザイン
    • 抑制要因
      • 耳管挿入に伴う合併症や副作用
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • パイプライン分析
  • 特許分析
  • DMIオピニオン

第6章 COVID-19分析

第7章 素材別

  • シリコーンチューブ
  • フッ素樹脂チューブ
  • 金属チューブ
  • その他

第8章 適応症別

  • 中耳炎
    • その他
  • 耳管機能障害
  • その他

第9章 エンドユーザー別

  • 病院
  • 耳鼻咽喉科クリニック
  • 外来手術センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Anthony Products, Inc.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Olympus America
  • Adept Medical
  • Atos Medical AB
  • Summit Medical LLC
  • Medtronic
  • Smith+Nephew
  • Heinz Kurz GmbH Medizintechnik
  • Hummingbird TTS Preceptis Medical
  • Invotec International Inc.

第13章 付録

目次
Product Code: MD7168

Overview

Ear tube devices, also known as tympanostomy tubes or ventilation tubes, are small, typically cylindrical implants used to treat conditions like chronic otitis media with effusion (fluid buildup in the middle ear) or recurrent ear infections. These tubes are inserted into the eardrum through a minor surgical procedure, creating a temporary passage that equalizes pressure and drains fluid from the middle ear. Their primary purpose is to alleviate symptoms, improve hearing, and prevent recurring infections.

Ear tubes are typically composed of different materials such as silicone, plastic, or metal, selected for their biocompatibility and durability. They play a vital role in treating persistent ear problems in individuals, especially children, by improving their ear health and overall quality of life.

Market Dynamics: Drivers and Restraints

Innovative ear tube design uses liquid-infused materials to enhance treatment results for ear infections is expected to drive market growth

In 2023, a team of researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard John A. Paulson School of Engineering and Applied Sciences, and Massachusetts Eye and Ear in Boston collaborated to create a revolutionary new type of ear tube device called "tympanostomy tubes" (TTs). These tubes use a liquid-infused material and have a unique curved lumen shape that enhances drug delivery, and fluid drainage and prevents bacterial adhesion.

The ear tube devices market is expected to experience growth with the introduction of innovative iTTs "tympanostomy tubes" (TTs) that possess enhanced functionality and potential for clinical trials in human patients. These iTTs provide a significant advancement in addressing the limitations of conventional TTs, making them a preferred treatment option for healthcare providers and parents seeking improved treatment options for ear infections, especially in children. This technology's versatility in design approach for other implantable medical conduits, such as shunts for the brain and bile ducts, could expand the market's scope and appeal to a broader range of medical professionals and patients.

Therefore, this innovation has the potential to revolutionize the market for ear tube devices by providing safer, more efficient, and customizable solutions for patients with middle ear conditions. This will drive demand and investment in the healthcare sector.

Furthermore, the growing geriatric population, rising awareness about the benefits of ear tubes, increasing incidence of ear infections, and increasing demand for minimally invasive procedures are the factors expected to drive the market over the forecast period.

Restraint:

Lack of awareness among patients and healthcare professionals about the benefits of ear tube devices, and alternative treatments, such as medication or watchful waiting, may be preferred by some patients or physicians. Additionally, concerns about potential complications or side effects associated with ear tube insertion may further contribute to this preference. As a result of these factors, the market for ear tube devices is expected to hamper over the forecast period.

Segment Analysis

The global ear tube devices market is segmented based on material, indication, end user, and region.

The silicone tubes from the material segment accounted for approximately 36.6% of the ear tube devices market share

Silicone tubes are frequently used in ear tubes, also known as tympanostomy tubes or grommets. Their inherent softness, flexibility, and biocompatibility make them ideal for situations where patient comfort and compatibility with delicate bodily tissues are crucial. These qualities are highly valued in pediatric ear tube surgeries, where the gentle nature of silicone tubes helps to minimize the risk of tissue damage during insertion.

Additionally, they provide a comfortable and dependable solution for treating conditions like chronic ear infections and middle ear ventilation issues in young patients, ensuring their well-being throughout the treatment process. Furthermore, the increasing prevalence of ear disorders, growth in the number of children with ear issues, advantages of silicone tubes, and awareness about the benefits of ear tubes are the factors expected to drive the market over the forecast period.

For instance, the World Health Organization (WHO) has reported that there are currently 1.5 billion people around the world living with some level of hearing impairment. Out of this number, 430 million are facing disabling hearing loss. It is projected that by the year 2050, this number will rise to more than 700 million. Notably, over a quarter of individuals aged 60 and above grapple with disabling hearing loss, and approximately 30% of this age group suffer from some form of hearing impairment.

Also, globally, 34 million children are affected by deafness or hearing loss, with a concerning 60% of these cases stemming from preventable causes. This highlights the urgent need for hearing-related interventions, such as ear tube devices, to address hearing problems across different age groups and demographics. This is especially important for pediatric populations.

Moreover, Collar Button Ear Tubes represent a distinct category of silicone ear tubes known for their exceptional softness, flexibility, and elasticity. They are incredibly flexible and can be easily manipulated and compressed, which makes the process of insertion and removal simpler. This exceptional design feature makes Collar Button Ear Tubes a preferred choice for healthcare professionals who are looking to address ear-related conditions, as they provide a more user-friendly and efficient solution for patients requiring ear tube placement. Hence, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Analysis

North America accounted for approximately 40.7% of the market share in 2022

North America is expected to hold the largest market share owing to the FDA approvals of ear tube devices, the increasing prevalence of ear disorders, and the development of novel ear tube devices by research institutes.

For instance, on August 15, 2022, Preceptis Inc. was granted an expanded clearance by the U.S. FDA for its Hummingbird Tympanostomy Tube System, allowing for office-based pediatric ear tube procedures in all children six months and older. The device was previously cleared for children aged 6-24 months. The minimally invasive device is designed to create an incision in the ear canal, enabling the delivery of the ear tube in a single pass without requiring general anesthesia.

Additionally, in 2023, a new ear tube was developed by Harvard researchers to enhance treatment outcomes for patients with ear infections. The tube is made up of liquid-infused materials and optimized geometry to prevent blockages and improve performance. The design was created using a screening algorithm and has fluid transport properties. This innovative design is anticipated to decrease the number of visits for children suffering from chronic ear infections and improve results for patients with ear-related ailments. Thus, owing to the above factors, the North America region is expected to hold the largest market share over the forecast period.

COVID-19 Impact Analysis:

COVID-19 had a significant impact on the ear tube devices market. Otolaryngologists, along with their staff, are at a higher risk of contracting COVID-19 due to their direct exposure to mucus and aerosolized particles during procedures and examinations in the head and neck area. Reports from countries like China, Italy, Iran, and the United Kingdom indicate that otolaryngologists are among the most vulnerable to contracting the SARS-CoV-2 virus, especially if they are not wearing appropriate personal protective equipment (PPE).

Moreover, according to the National Center for Biotechnology Information, 2022, the incidence of otitis media was drastically reduced, the incidence of complications of otitis media was reduced, and the number of patients visiting the emergency room due to otitis media decreased.

Additionally, due to the COVID-19 pandemic, there has been a significant decrease in the rate of pediatric tympanostomy tube placement. The age of patients undergoing surgery has increased and more children are receiving care in a tertiary setting. These findings may indicate changes in the prevalence of acute and chronic otitis media caused by the pandemic.

Therefore, the COVID-19 pandemic impacted the use of ear tube devices by decreasing the number of tympanostomy tube placements, increasing the risk of infection, decreasing middle ear effusion, generating aerosols during myringotomy, and causing ear pressure.

Competitive Landscape

The major global players in the ear tube devices market include: Anthony Products, Inc., Olympus America, Adept Medical, Atos Medical AB, Summit Medical LLC, Medtronic, Smith+Nephew, Heinz Kurz GmbH Medizintechnik, Hummingbird TTS Preceptis Medical, and Invotec International Inc. among others.

Key Developments

  • On August 15, 2022, Preceptis Medical, Inc. is a surgical technology company that focuses on providing less invasive options for pediatric patients. The Hummingbird Tympanostomy Tube System (TTS) received clearance from the U.S. FDA for expanded indications for use in office-based pediatric ear tube procedures. This new labeling now allows in-office procedures for all children six months and older, whereas it was previously only cleared for children aged 6-24 months.
  • On June 2, 2021, Preceptis Medical launched its Hummingbird tympanostomy tube system for office-based pediatric ear tube procedures.
  • On January 24, 2020, Smith & Nephew acquired Tusker Medical for an undisclosed sum. Tusker Medical is the developer of the Tula System, an in-office ear tube delivery system used to treat recurrent or persistent ear infections. The pediatric ear tubes received FDA breakthrough device designation in November 2019.

Why Purchase the Report?

  • To visualize the global ear tube devices market segmentation based on material, indication, end user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of ear tube devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global ear tube devices market report would provide approximately 61 tables, 59 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material
  • 3.2. Snippet by Indication
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovative ear tube design using liquid-infused materials
    • 4.1.2. Restraints
      • 4.1.2.1. Complications or side effects associated with ear tube insertion
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Pipeline Analysis
  • 5.6. Patent Analysis
  • 5.7. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Material

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 7.1.2. Market Attractiveness Index, By Material
  • 7.2. Silicone Tubes*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Fluoroplastic Tubes
  • 7.4. Metal Tubes
  • 7.5. Others

8. By Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 8.1.2. Market Attractiveness Index, By Indication
  • 8.2. Otitis Media*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
      • 8.2.2.1. Others
  • 8.3. Eustachian Tube Dysfunction
  • 8.4. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. ENT Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Anthony Products, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Olympus America
  • 12.3. Adept Medical
  • 12.4. Atos Medical AB
  • 12.5. Summit Medical LLC
  • 12.6. Medtronic
  • 12.7. Smith+Nephew
  • 12.8. Heinz Kurz GmbH Medizintechnik
  • 12.9. Hummingbird TTS Preceptis Medical
  • 12.10. Invotec International Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us